63 /100
HIGH RISK
Score updated Apr 13, 2026

LYRA

Lyra Therapeutics, Inc. — Stock Dilution Tracker

Track LYRA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track LYRA — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
62
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
26%
🔄 Reverse Split 40%
• 50-day avg $1.06 approaching $1 threshold
• 11 months cash with weak price
💰 Capital Raise 15%
• Under 12 months cash (11mo)
📉 Score Deterioration 10%
• Score in HIGH risk zone (63/100)
🔔 Track LYRA — Get forecast alerts →
💹 Market Data
Market Cap$1.15M
Shares Outstanding1.77M
Float395.7K
Cash$15.89M
Debt$30.26M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 46.0% shares (2025Q4 vs prior)
24 institutional holders · 242.7K shares
#1 SABBY MANAGEMENT, LLC 175.2K shares
#2 Ikarian Capital, LLC 21.2K shares
#3 DRW Securities, LLC 16.8K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest56.9K
Days to Cover1.0
% of Float14.4%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Sep 30, 2024
xbrl XBRL CONVERTIBLE Dec 31, 2020
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track LYRA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LYRA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required